Vabiotech licenses Inviragen technology for Japanese encephalitis vaccine production
Under the license, VABIOTECH is expected to develop and commercialize JE vaccine in Vietnam, Cambodia and Myanmar. In addition, VABIOTECH will provide certain development-based milestone payments to Inviragen.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.